MedTrace Logo

CancerLife: Patient-Driven Solution in Cancer Care

NCT03371147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-09

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the use of a digital information and communication platform (DICP) in improving outcomes in patients with cancer and their caregivers.

Conditions

Interventions

OTHER

CancerLife

CancerLife is a patient facing messaging app that gives cancer survivors and caregivers the ability to update family and friends of their health status through their existing social networks and at the same collect psychosocial and symptom reports that can be shared with the patients care team.

Sponsors & Collaborators

  • Healthy Platforms, LLC

    collaborator UNKNOWN

  • Saint John's Cancer Institute

    lead OTHER

Principal Investigators

  • Santosh Kesari, MD PhD · Saint John's Cancer Institute

  • Marlon G Saria, PhD RN FAAN · John Wayne Cancer Institute at Providence Saint John's Health Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2020-01-07
Completion
2020-01-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371147 on ClinicalTrials.gov